Biodegradable cement augmentation of gamma nail osteosynthesis reduces migration in pertrochanteric fractures, a biomechanical in vitro study.


Journal

Clinical biomechanics (Bristol, Avon)
ISSN: 1879-1271
Titre abrégé: Clin Biomech (Bristol, Avon)
Pays: England
ID NLM: 8611877

Informations de publication

Date de publication:
04 2021
Historique:
received: 28 05 2020
revised: 09 03 2021
accepted: 13 03 2021
pubmed: 28 3 2021
medline: 26 11 2021
entrez: 27 3 2021
Statut: ppublish

Résumé

Cut-out of gamma nail often results from poor primary bone stability, suboptimal reduction (varus) and excentric placement of the head element which may lead to "instability" and frequently requires revision. Various studies have shown that augmentation with polymethylmethacrylate cement increases the primary stability of osteosynthesis. However, it has not yet been widely used in fracture treatment due to certain disadvantages, e.g., the lack of osteointegration, the formation of an interface membrane or the presence of toxic monomers. Few studies show that biodegradable bone cements increase the stability of osteosynthesis in different anatomical regions and therefore could be an alternative to polymethylmethacrylate cement in the treatment of pertrochanteric fractures. Two biomechanical situations were simulated using 24 Sawbones (simple and multifragmentary pertrochanteric fractures; AO-classification 31-A1 and 31-A2. Both groups were stabilized using the Gamma3® nailing system with and without biodegradable bone cement. Sawbones underwent the same cyclic loading test, simulating 10.000 gait cycles loading the bones with three times body weight. Migration was determined by comparing computed tomography scans recorded before and after the mechanical testing. The three-dimensional migration of the lag screw was calculated, and the rotation of the head around the longitudinal axis was determined. Biodegradable cement reduced migration by approximately 35% in 31-A1 fractures (25.4% in 31-A2 fractures) and the rotation of the head around the lag screw by approximately 37% in 31-A1 fractures (17.8%, 31-A2). Use of biodegradable bone cement improved the primary stability of gamma nail osteosynthesis in the biomechanical model.

Sections du résumé

BACKGROUND
Cut-out of gamma nail often results from poor primary bone stability, suboptimal reduction (varus) and excentric placement of the head element which may lead to "instability" and frequently requires revision. Various studies have shown that augmentation with polymethylmethacrylate cement increases the primary stability of osteosynthesis. However, it has not yet been widely used in fracture treatment due to certain disadvantages, e.g., the lack of osteointegration, the formation of an interface membrane or the presence of toxic monomers. Few studies show that biodegradable bone cements increase the stability of osteosynthesis in different anatomical regions and therefore could be an alternative to polymethylmethacrylate cement in the treatment of pertrochanteric fractures.
METHODS
Two biomechanical situations were simulated using 24 Sawbones (simple and multifragmentary pertrochanteric fractures; AO-classification 31-A1 and 31-A2. Both groups were stabilized using the Gamma3® nailing system with and without biodegradable bone cement. Sawbones underwent the same cyclic loading test, simulating 10.000 gait cycles loading the bones with three times body weight. Migration was determined by comparing computed tomography scans recorded before and after the mechanical testing. The three-dimensional migration of the lag screw was calculated, and the rotation of the head around the longitudinal axis was determined.
FINDINGS
Biodegradable cement reduced migration by approximately 35% in 31-A1 fractures (25.4% in 31-A2 fractures) and the rotation of the head around the lag screw by approximately 37% in 31-A1 fractures (17.8%, 31-A2).
INTERPRETATION
Use of biodegradable bone cement improved the primary stability of gamma nail osteosynthesis in the biomechanical model.

Identifiants

pubmed: 33773169
pii: S0268-0033(21)00057-7
doi: 10.1016/j.clinbiomech.2021.105327
pii:
doi:

Substances chimiques

Bone Cements 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105327

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Matthias Bungartz (M)

Department of Orthopaedics, Waldkliniken Eisenberg, Chair of the Jena University Hospital, Klosterlausnitzer Straße 81, 07607 Eisenberg, Germany. Electronic address: m.bungartz@waldkliniken-eisenberg.de.

Georg Matziolis (G)

Department of Orthopaedics, Waldkliniken Eisenberg, Chair of the Jena University Hospital, Klosterlausnitzer Straße 81, 07607 Eisenberg, Germany.

Frank Layher (F)

Department of Orthopaedics, Waldkliniken Eisenberg, Chair of the Jena University Hospital, Klosterlausnitzer Straße 81, 07607 Eisenberg, Germany.

Victoria Horbert (V)

Experimental Rheumatology Unit, Jena University Hospital, Germany.

Alexander Maslaris (A)

Department of Orthopaedics, Waldkliniken Eisenberg, Chair of the Jena University Hospital, Klosterlausnitzer Straße 81, 07607 Eisenberg, Germany.

Olaf Brinkmann (O)

Department of Orthopaedics, Waldkliniken Eisenberg, Chair of the Jena University Hospital, Klosterlausnitzer Straße 81, 07607 Eisenberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH